SCOPUS 정보 검색 플랫폼

Volumn 15, Issue 85, 2006, Pages 182-183

Oseltamivir: Cutaneous and neurological adverse effects in children

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; OSELTAMIVIR; PLACEBO;

ANAPHYLAXIS; APATHY; ARTICLE; BEHAVIOR DISORDER; CAUSE OF DEATH; CHILD; CLINICAL TRIAL; CONFUSION; CONVULSION; DELIRIUM; DROWSINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FOOD AND DRUG ADMINISTRATION; HALLUCINATION; HIGH RISK PATIENT; HUMAN; HYPOTHERMIA; IMMOBILIZATION; INFLUENZA; JAPAN; MORTALITY; MYDRIASIS; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; NEUROTOXICITY; NONHUMAN; RESPIRATION DEPRESSION; RISK BENEFIT ANALYSIS; SEIZURE; SIDE EFFECT; SKIN DISEASE; STEVENS JOHNSON SYNDROME; STRABISMUS; SUICIDE; TOXIC EPIDERMAL NECROLYSIS; TREMOR;

ADOLESCENT; ADULT; ANIMALS; ANTIVIRAL AGENTS; CHILD; EUROPE; HUMANS; INFLUENZA, HUMAN; NERVOUS SYSTEM DISEASES; OSELTAMIVIR; RATS; SKIN DISEASES; SUICIDE; TREATMENT OUTCOME; UNITED STATES;

EID: 33749354627 PISSN: 11677422 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (11)

References (8)

1
- 31944444952
- "Antiviral drugs in influenza"
- Prescrire Editorial Staff
- Prescrire Editorial Staff "Antiviral drugs in influenza" Prescrire Int 2006; 15 (81): 21-30.
- (2006) Prescrire Int , vol.15 , Issue.81 , pp. 21-30

2
- 33749316514
- o"
- U.S. Food and Drug Administration - Pediatric advisory committee meeting 18 November Website accessed 15 December 2005
- o" 18 November 2005. Website http://www.fda.gov accessed 15 December 2005.
- (2005)

3
- 33749315622
- "One-year post pediatric exclusivity postmarketing adverse events review. Drug: Oseltamivir phosphate"
- U.S. Food and Drug Administration - Division of drug risk evaluation 24 August Website accessed 2 Match 2006
- U.S. Food and Drug Administration - Division of drug risk evaluation "One-year post pediatric exclusivity postmarketing adverse events review. Drug: oseltamivir phosphate" 24 August 2005. Website http://www.fda.gov accessed 2 Match 2006,
- (2005)

4
- 15944364935
- "Dear Health Care Professional"
- U.S. Food and Drug Administration - Roche Pharmaceuticals December Website accessed 15 December 2005
- U.S. Food and Drug Administration - Roche Pharmaceuticals "Dear health care professional" December 2003. Website http://www.fda.gov accessed 15 December 2005.
- (2003)

5
- 33749347723
- "New type of influenza -related encephalopathy or new adverse drug reaction?"
- Website accessed 15 December
- Hama R "New type of influenza -related encephalopathy or new adverse drug reaction?" bmj.com rapid responses. Website http://www.bmj.com accessed 15 December 2005.
- (2005) Bmj.Com Rapid Responses
- Hama, R.¹

6
- 33749369640
- o"
- European Medicines Agency 23 February Website accessed 18 February 2006
- o" 23 February 2005. Website http://www.emea.eu.int accessed 18 February 2006.
- (2005)

7
- 33749341629
- "Press release. European medicines agency update on the safety of Tamiflu"
- European Medicines Agency 17 November Website accessed 18 December 2005
- European Medicines Agency "Press release. European medicines agency update on the safety of Tamiflu" 17 November 2005. Website http://www.emea.eu.int accessed 18 December 2005.
- (2005)

8
- 33749357276
- o (oseltamivir)"
- Agence française de sécurité sanitaire des produits de santé 15 December Website accessed 16 December 2005
- o (oseltamivir)" 15 December 2005. Website http://afssaps.sante.fr accessed 16 December 2005.
- (2005)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.